220 related articles for article (PubMed ID: 18470881)
21. Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton.
Krendel M; Zenke FT; Bokoch GM
Nat Cell Biol; 2002 Apr; 4(4):294-301. PubMed ID: 11912491
[TBL] [Abstract][Full Text] [Related]
22. Lbc proto-oncogene product binds to and could be negatively regulated by metastasis suppressor nm23-H2.
Iwashita S; Fujii M; Mukai H; Ono Y; Miyamoto M
Biochem Biophys Res Commun; 2004 Aug; 320(4):1063-8. PubMed ID: 15249197
[TBL] [Abstract][Full Text] [Related]
23. Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells.
Liu F; Qi HL; Chen HL
J Cancer Res Clin Oncol; 2000 Feb; 126(2):85-90. PubMed ID: 10664247
[TBL] [Abstract][Full Text] [Related]
24. Nm23-H1 suppresses hepatocarcinoma cell adhesion and migration on fibronectin by modulating glycosylation of integrin beta1.
She S; Xu B; He M; Lan X; Wang Q
J Exp Clin Cancer Res; 2010 Jul; 29(1):93. PubMed ID: 20618991
[TBL] [Abstract][Full Text] [Related]
25. Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma.
Wang YF; Chen JY; Chang SY; Chiu JH; Li WY; Chu PY; Tai SK; Wang LS
Int J Cancer; 2008 Jan; 122(2):377-86. PubMed ID: 17918157
[TBL] [Abstract][Full Text] [Related]
26. Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1.
Aktary Z; Chapman K; Lam L; Lo A; Ji C; Graham K; Cook L; Li L; Mackey JR; Pasdar M
Oncogene; 2010 Apr; 29(14):2118-29. PubMed ID: 20101217
[TBL] [Abstract][Full Text] [Related]
27. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells.
Olivo C; Vanni C; Mancini P; Silengo L; Torrisi MR; Tarone G; Defilippi P; Eva A
Oncogene; 2000 Mar; 19(11):1428-36. PubMed ID: 10723134
[TBL] [Abstract][Full Text] [Related]
28. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.
Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS
Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300
[TBL] [Abstract][Full Text] [Related]
29. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.
Ridgway LD; Wetzel MD; Ngo JA; Erdreich-Epstein A; Marchetti D
Mol Cancer Res; 2012 Jun; 10(6):689-702. PubMed ID: 22513363
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of the nucleotide exchange factor ITSN1L: evidence for a kinetic discrimination of GEF-stimulated nucleotide release from Cdc42.
Kintscher C; Groemping Y
J Mol Biol; 2009 Mar; 387(2):270-83. PubMed ID: 19356586
[TBL] [Abstract][Full Text] [Related]
31. P53 is a regulator of the metastasis suppressor gene Nm23-H1.
Chen SL; Wu YS; Shieh HY; Yen CC; Shen JJ; Lin KH
Mol Carcinog; 2003 Apr; 36(4):204-14. PubMed ID: 12669312
[TBL] [Abstract][Full Text] [Related]
32. Metastasis suppressor Nm23-H1 inhibits STAT3 signaling via a negative feedback mechanism.
Gong L; Wu Z; Guo L; Li L; Zhao R; Zhu D; Zhou Q
Biochem Biophys Res Commun; 2013 May; 434(3):541-6. PubMed ID: 23583378
[TBL] [Abstract][Full Text] [Related]
33. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer.
Fiore LS; Ganguly SS; Sledziona J; Cibull ML; Wang C; Richards DL; Neltner JM; Beach C; McCorkle JR; Kaetzel DM; Plattner R
Oncogene; 2014 Sep; 33(36):4508-4520. PubMed ID: 24096484
[TBL] [Abstract][Full Text] [Related]
34. Dbl oncogene expression in MCF-10 A epithelial cells disrupts mammary acinar architecture, induces EMT and angiogenic factor secretion.
Vanni C; Ognibene M; Finetti F; Mancini P; Cabodi S; Segalerba D; Torrisi MR; Donnini S; Bosco MC; Varesio L; Eva A
Cell Cycle; 2015; 14(9):1426-37. PubMed ID: 25723869
[TBL] [Abstract][Full Text] [Related]
35. Small molecule activator of Nm23/NDPK as an inhibitor of metastasis.
Lee JJ; Kim HS; Lee JS; Park J; Shin SC; Song S; Lee E; Choi JE; Suh JW; Lee H; Kim EE; Seo EK; Shin DH; Lee HY; Lee HY; Lee KJ
Sci Rep; 2018 Jul; 8(1):10909. PubMed ID: 30026594
[TBL] [Abstract][Full Text] [Related]
36. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
[TBL] [Abstract][Full Text] [Related]
37. Altered gene and protein expression by Nm23-H1 in metastasis suppression.
Lee JH; Marshall JC; Steeg PS; Horak CE
Mol Cell Biochem; 2009 Sep; 329(1-2):141-8. PubMed ID: 19415462
[TBL] [Abstract][Full Text] [Related]
38. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
39. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
Leone A; Flatow U; VanHoutte K; Steeg PS
Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
[TBL] [Abstract][Full Text] [Related]
40. The multiple regulation of metastasis suppressor NM23-H1 in cancer.
Yu L; Wang X; Zhang W; Khan E; Lin C; Guo C
Life Sci; 2021 Mar; 268():118995. PubMed ID: 33421524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
